Halozyme Therapeutics Inc
F:RV7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Halozyme Therapeutics Inc
F:RV7
|
US |
|
M
|
Meta Platforms Inc
XMUN:FB2A
|
US |
Shareholder Yield
Current shareholder yield for
RV7 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
RV7 Price
Halozyme Therapeutics Inc
| Average Annual Return | 27.42% |
| Standard Deviation of Annual Returns | 38.29% |
| Max Drawdown | -51% |
| Market Capitalization | 12.5B EUR |
| Shares Outstanding | 127 186 000 |
| Percentage of Shares Shorted |
N/A
|